Technical Analysis for AKBA - Akebia Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 5.5 -2.14% -0.12
AKBA closed down 2.14 percent on Friday, May 17, 2019, on 61 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical AKBA trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction -2.14%
Down 3 Days in a Row Weakness -2.14%

Older signals for AKBA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. Its lead product candidate is AKB-6548, a HIF-PH inhibitor, which is in Phase IIb clinical trials for patients with anemia secondary to chronic kidney disease who are not dependent on dialysis. The company is also developing a development program for patients dependent on dialysis. Akebia Therapeutics, Inc. was founded in 2007 and is headquartered in Cambridge, Massachusetts.
Biopharmaceutical Dialysis Chronic Kidney Disease Anemia Kidney Kidney Disease Hypoxia Inducible Factors
Is AKBA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.6
52 Week Low 5.2
Average Volume 1,414,085
200-Day Moving Average 7.4286
50-Day Moving Average 7.1008
20-Day Moving Average 6.1155
10-Day Moving Average 5.896
Average True Range 0.3264
ADX 33.08
+DI 9.6898
-DI 28.9032
Chandelier Exit (Long, 3 ATRs ) 6.2008
Chandelier Exit (Short, 3 ATRs ) 6.3992
Upper Bollinger Band 6.7418
Lower Bollinger Band 5.4892
Percent B (%b) 0.01
BandWidth 20.482381
MACD Line -0.3822
MACD Signal Line -0.3624
MACD Histogram -0.0198
Fundamentals Value
Market Cap 100.65 Million
Num Shares 18.3 Million
EPS -3.60
Price-to-Earnings (P/E) Ratio -1.53
Price-to-Sales 6.10
Price-to-Book 12.65
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.80
Resistance 3 (R3) 5.81 5.71 5.75
Resistance 2 (R2) 5.71 5.64 5.71 5.73
Resistance 1 (R1) 5.61 5.59 5.56 5.60 5.72
Pivot Point 5.51 5.51 5.49 5.51 5.51
Support 1 (S1) 5.41 5.44 5.36 5.40 5.28
Support 2 (S2) 5.31 5.39 5.31 5.27
Support 3 (S3) 5.21 5.31 5.25
Support 4 (S4) 5.20